Jukka Westerbacka

10.3k citations

96 papers · 8.1k indexed · 2 hit papers · h-index 46

Impact in

Endocrinology, Diabetes and Metabolism top 0.2%
- Diet, Metabolism, and Disease
- Diabetes, Cardiovascular Risks, and Lipoproteins
Epidemiology top 0.5%
- Liver Disease Diagnosis and Treatment
- Adipokines, Inflammation, and Metabolic Diseases

Papers in

Endocrinology, Diabetes and Metabolism 58
- Diabetes Management and Research 27
- Diabetes Treatment and Management 26
- Diabetes, Cardiovascular Risks, and Lipoproteins 17
- Diet, Metabolism, and Disease 9
Cardiology and Cardiovascular Medicine 31
- Cardiovascular Health and Disease Prevention 19
- Cardiovascular Function and Risk Factors 11
- Blood Pressure and Hypertension Studies 10

Co-authors: Hannele Yki‐Järvinen Satu Vehkavaara Anna‐Maija Häkkinen Anna Kotronen Juha Halavaara Marja‐Riitta Taskinen Anneli Seppälä‐Lindroos Robert Bergholm
Journals: Diabetes (16 papers)Diabetes Obesity and Metabolism (12 papers)Diabetologia (8 papers)The Journal of Clinical Endocrinology & Metabolism (8 papers)Arteriosclerosis Thrombosis and Vascular Biology (5 papers)
Partner nations: Finland Sweden United Kingdom

In The Last Decade

Jukka Westerbacka

92 papers receiving 7.9k citations

Hit Papers

align trajectories log scale

Overproduction of large VLDL particles is driven by increased liver fat content in man 2006 · 537 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2006 Diabetologia
2002 The Journal of Clinical Endocrinology & Metabolism

Peers

Countries citing papers authored by Jukka Westerbacka

Since Specialization

Citations

This map shows the geographic impact of Jukka Westerbacka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jukka Westerbacka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jukka Westerbacka more than expected).

Fields of papers citing papers by Jukka Westerbacka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jukka Westerbacka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jukka Westerbacka. The network helps show where Jukka Westerbacka may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jukka Westerbacka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jukka Westerbacka Line = papers co-authored together Jukka Westerbacka links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	C ontinuous glucose monitoring‐based time‐in‐range using insulin glargine 300 units/ ml versus insulin degludec 100 units/ ml in type 1 diabetes: The head‐to‐head randomized controlled InRange trial Diabetes Obesity and Metabolism ·Tadej Battelino, Thomas Danne, Steve Edelman, Pratik Choudhary, Éric Renard, Jukka Westerbacka, B.N. Mukherjee, Valérie Pilorget, Mathieu Coudert, Richard M. Bergenstal	2022	20
2	Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: A subanalysis of the BRIGHT study Diabetes Obesity and Metabolism ·Alice Cheng, Stewart B. Harris, Francesco Giorgino, Jochen Seufert, Robert Ritzel, Kamlesh Khunti, Sarthak Joshi, Mario Teixeira, Jukka Westerbacka, Zsolt Bosnyák, Julio Rosenstock	2019	5
3	Change in Insulin Dose and HbA1c by Geographical Region—Results from the Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) Study Diabetes ·Dı́dac Mauricio, Luigi Meneghini, Emanuela Orsi, Vadim V. Klimontov, Jukka Westerbacka, Mario Teixeira, Valérie Pilorget, Riccardo Perfetti, Kamlesh Khunti	2018	1
4	Ultra-acute increase in blood glucose during prehospital phase is associated with worse short-term and long-term survival in ST-elevation myocardial infarction Scandinavian Journal of Trauma Resuscitation and Emergency Medicine ·J. Edward Hedges, Ilkka Tierala, Markku Kuisma, Della Widyasari, Jukka Westerbacka, Jouni Nurmi	2014	3
5	Strict Glucose Control After Acute Stroke Can Be Provided in the Prehospital Setting Academic Emergency Medicine ·Jouni Nurmi, Perttu J. Lindsberg, Olli Häppölä, H. Kachwalla, Jukka Westerbacka, Maaret Castrén	2011	14
6	Splanchnic Balance of Free Fatty Acids, Endocannabinoids, and Lipids in Subjects With Nonalcoholic Fatty Liver Disease Gastroenterology ·Jukka Westerbacka, Anna Kotronen, Barbara A. Fielding, John Wahren, Leanne Hodson, Julia Perttilä, Tuulikki Seppänen‐Laakso, Tapani Suortti, Johanna Arola, Rolf Hultcrantz, Sandra Castillo, Vesa M. Olkkonen, Keith N. Frayn, Matej Orešič, Hannele Yki‐Järvinen	2010	57
7	Splanchnic balance of free fatty acids, endocannabinoids and lipids in subjects with NAFLD Diabetologia ·Anna Kotronen, Jukka Westerbacka, BA Fielding, J. Wahren, Leanne Hodson, Tuulikki Seppänen‐Laakso, Tapani Suortti, Johanna Arola, R. Hultcrantz, Sandra Castillo, Keith N. Frayn, Matej Orešič, Hannele Yki‐Järvinen	2010	0
8	Allele-specific regulation of MTTP expression influences the risk of ischemic heart disease Journal of Lipid Research ·유창달, Esra NEMLİ ÇALIŞKAN, Petra Thulin, 陈旭毅, 田中正司, Elisabeth Strandhagen, Ioannis Nomidis, Ulf Lidberg, Jukka Westerbacka, Anders Franco‐Cereceda, Jan Liška, Lars B. Nielsen, Mats Gåfvels, Maria Mannila, Anders Hamsten, Hannele Yki‐Järvinen, Dag S. Thelle, Per Eriksson, Jan Borén, Ewa Ehrenborg	2009	19
9	Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations Diabetologia ·Anna Kotronen, Vidya Velagapudi, Laxman Yetukuri, Jukka Westerbacka, Robert Bergholm, Kim Ekroos, Janne Makkonen, Marja‐Riitta Taskinen, Matej Orešič, Hannele Yki‐Järvinen	2009	157
10	Liver Fat Is Increased in Type 2 Diabetic Patients and Underestimated by Serum Alanine Aminotransferase Compared With Equally Obese Nondiabetic Subjects Diabetes Care ·Anna Kotronen, Leena Juurinen, Antti Hakkarainen, Jukka Westerbacka, A. H. Corner, Robert Bergholm, Hannele Yki‐Järvinen	2007	152
11	Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance Diabetologia ·Martin Adiels, Jukka Westerbacka, Aino Soro‐Paavonen, A.‐M. Häkkinen, Satu Vehkavaara, Muriel Caslake, C.J. Packard, S. Olofsson, Hannele Yki‐Järvinen, Marja‐Riitta Taskinen, Jan Borén	2007	153
12	Overproduction of large VLDL particles is driven by increased liver fat content in man Diabetologia ·Martin Adiels, Marja‐Riitta Taskinen, Chris J. Packard, Muriel Caslake, Aino Soro‐Paavonen, Jukka Westerbacka, Satu Vehkavaara, Coordenação Geral de Acompanhamento Pedagógico, S.‐O. Olofsson, Hannele Yki‐Järvinen, Jan Borén Hit paper breakdown →	2006	537
13	The Fatty Liver and Insulin Resistance Current Molecular Medicine ·H Yki-Järvinen, Jukka Westerbacka	2005	93
14	Increased augmentation of central blood pressure is associated with increases in carotid intima–media thickness in type 2 diabetic patients Diabetologia ·Jukka Westerbacka, Eeva Leinonen, Jukka T. Salonen, Riitta Salonen, Anne Hiukka, Hannele Yki‐Järvinen, Marja‐Riitta Taskinen	2005	43
15	Dietary Fat Content Modifies Liver Fat in Overweight Nondiabetic Subjects The Journal of Clinical Endocrinology & Metabolism ·Jukka Westerbacka, 杨海双, Anna‐Maija Häkkinen, Aila Rissanen, Irma Salminen, Antti Aro, Hannele Yki‐Järvinen	2005	304
16	Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins American Journal of Physiology-Endocrinology and Metabolism ·Kirsi H. Pietiläinen, Aila Rissanen, Jaakko Kaprio, Sari Mäkimattila, Anna‐Maija Häkkinen, Jukka Westerbacka, Jussi Sutinen, Satu Vehkavaara, Hannele Yki‐Järvinen	2004	79
17	Insulin therapy improves insulin actions on glucose metabolism and aortic wave reflection in type 2 diabetic patients European Journal of Clinical Investigation ·Marjo Tamminen, Jukka Westerbacka, Satu Vehkavaara, Hannele Yki‐Järvinen	2003	14
18	Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy AIDS ·Jussi Sutinen, Anna‐Maija Häkkinen, Jukka Westerbacka, Anneli Seppälä‐Lindroos, Satu Vehkavaara, Juha Halavaara, Asko Järvinen, Matti Ristola, Hannele Yki‐Järvinen	2002	148
19	Fat Accumulation in the Liver Is Associated with Defects in Insulin Suppression of Glucose Production and Serum Free Fatty Acids Independent of Obesity in Normal Men The Journal of Clinical Endocrinology & Metabolism ·Anneli Seppälä‐Lindroos, Satu Vehkavaara, Anna‐Maija Häkkinen, Takashi Goto, Jukka Westerbacka, Anssi Sovijärvi, Juha Halavaara, Hannele Yki‐Järvinen Hit paper breakdown →	2002	855
20	Vascular actions of insulin in obesity International Journal of Obesity ·Hannele Yki‐Järvinen, Jukka Westerbacka	2000	26

About Jukka Westerbacka

Jukka Westerbacka is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Epidemiology, Family Practice and Virology, having authored 96 papers that have together received 8.1k indexed citations. Recurring topics across this work include Diabetes Management and Research (27 papers), Liver Disease Diagnosis and Treatment (26 papers), Diabetes Treatment and Management (26 papers), Cardiovascular Health and Disease Prevention (19 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (17 papers), Cardiovascular Function and Risk Factors (11 papers), Blood Pressure and Hypertension Studies (10 papers) and Diet, Metabolism, and Disease (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.7k citations), Epidemiology (4.1k citations), Cardiology and Cardiovascular Medicine (1.9k citations), Biochemistry (568 citations) and Physiology (2.0k citations). Jukka Westerbacka has collaborated with scholars based in Finland, Sweden and United Kingdom. Frequent co-authors include Hannele Yki‐Järvinen, Satu Vehkavaara, Anna‐Maija Häkkinen, Anna Kotronen, Juha Halavaara, Marja‐Riitta Taskinen, Anneli Seppälä‐Lindroos, Robert Bergholm, Tuula Kiviluoto and H Yki-Järvinen. Their work appears in journals such as Diabetes, Diabetes Obesity and Metabolism, Diabetologia, The Journal of Clinical Endocrinology & Metabolism and Arteriosclerosis Thrombosis and Vascular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact